PMYT1_HUMAN - dbPTM
PMYT1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PMYT1_HUMAN
UniProt AC Q99640
Protein Name Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
Gene Name PKMYT1
Organism Homo sapiens (Human).
Sequence Length 499
Subcellular Localization Endoplasmic reticulum membrane
Peripheral membrane protein . Golgi apparatus membrane
Peripheral membrane protein .
Protein Description Acts as a negative regulator of entry into mitosis (G2 to M transition) by phosphorylation of the CDK1 kinase specifically when CDK1 is complexed to cyclins. Mediates phosphorylation of CDK1 predominantly on 'Thr-14'. Also involved in Golgi fragmentation. May be involved in phosphorylation of CDK1 on 'Tyr-15' to a lesser degree, however tyrosine kinase activity is unclear and may be indirect. May be a downstream target of Notch signaling pathway during eye development..
Protein Sequence MLERPPALAMPMPTEGTPPPLSGTPIPVPAYFRHAEPGFSLKRPRGLSRSLPPPPPAKGSIPISRLFPPRTPGWHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQPRAWGVLWCMAAEALSRGWALWQALLALLCWLWHGLAHPASWLQPLGPPATPPGSPPCSLLLDSSLSSNWDDDSLGPSLSPEAVLARTVGSTSTPRSRCTPRDALDLSDINSEPPRGSFPSFEPRNLLSLFEDTLDPT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MLERPPAL
-------CCCCCCCC
8.7120068231
14PhosphorylationALAMPMPTEGTPPPL
CCCCCCCCCCCCCCC
40.5722199227
17PhosphorylationMPMPTEGTPPPLSGT
CCCCCCCCCCCCCCC
26.7925159151
22PhosphorylationEGTPPPLSGTPIPVP
CCCCCCCCCCCCCCC
46.5222199227
24PhosphorylationTPPPLSGTPIPVPAY
CCCCCCCCCCCCCCC
18.0522199227
31PhosphorylationTPIPVPAYFRHAEPG
CCCCCCCCCCCCCCC
8.6227273156
40PhosphorylationRHAEPGFSLKRPRGL
CCCCCCCCCCCCCCC
38.6130266825
42MethylationAEPGFSLKRPRGLSR
CCCCCCCCCCCCCCC
60.1982981881
42UbiquitinationAEPGFSLKRPRGLSR
CCCCCCCCCCCCCCC
60.19-
48PhosphorylationLKRPRGLSRSLPPPP
CCCCCCCCCCCCCCC
23.7320068231
50PhosphorylationRPRGLSRSLPPPPPA
CCCCCCCCCCCCCCC
41.6830266825
58UbiquitinationLPPPPPAKGSIPISR
CCCCCCCCCCCCHHH
59.99-
60PhosphorylationPPPPAKGSIPISRLF
CCCCCCCCCCHHHCC
25.2020068231
64PhosphorylationAKGSIPISRLFPPRT
CCCCCCHHHCCCCCC
19.9920068231
71PhosphorylationSRLFPPRTPGWHQLQ
HHCCCCCCCCCCCCC
31.7423312004
89PhosphorylationVSFRGEASETLQSPG
EEECCCHHHHHCCCC
27.1530266825
91PhosphorylationFRGEASETLQSPGYD
ECCCHHHHHCCCCCC
27.8330266825
94PhosphorylationEASETLQSPGYDPSR
CHHHHHCCCCCCCCC
24.3330266825
97PhosphorylationETLQSPGYDPSRPES
HHHCCCCCCCCCCHH
28.2330266825
100PhosphorylationQSPGYDPSRPESFFQ
CCCCCCCCCCHHHHH
58.5330266825
104PhosphorylationYDPSRPESFFQQSFQ
CCCCCCHHHHHHHHH
33.7630266825
109PhosphorylationPESFFQQSFQRLSRL
CHHHHHHHHHHHHCC
16.7426055452
120PhosphorylationLSRLGHGSYGEVFKV
HHCCCCCCCCCEEEE
25.0425159151
121PhosphorylationSRLGHGSYGEVFKVR
HCCCCCCCCCEEEEE
23.1528796482
126UbiquitinationGSYGEVFKVRSKEDG
CCCCCEEEEEECCCC
41.7521906983
126MethylationGSYGEVFKVRSKEDG
CCCCCEEEEEECCCC
41.7542359113
136PhosphorylationSKEDGRLYAVKRSMS
ECCCCCEEEEEECCC
14.1620068231
139UbiquitinationDGRLYAVKRSMSPFR
CCCEEEEEECCCCCC
30.50-
141PhosphorylationRLYAVKRSMSPFRGP
CEEEEEECCCCCCCH
20.2130266825
143PhosphorylationYAVKRSMSPFRGPKD
EEEEECCCCCCCHHH
23.3325159151
149UbiquitinationMSPFRGPKDRARKLA
CCCCCCHHHHHHHHH
63.77-
154UbiquitinationGPKDRARKLAEVGSH
CHHHHHHHHHHHCCC
51.5721906983
160PhosphorylationRKLAEVGSHEKVGQH
HHHHHHCCCCCCCCC
33.3825159151
163UbiquitinationAEVGSHEKVGQHPCC
HHHCCCCCCCCCCCE
46.36-
330PhosphorylationEFTAGLSSELRSVLV
HHHCCCCHHHHHHHH
45.7724719451
345UbiquitinationMMLEPDPKLRATAEA
HHHCCCHHHHHHHHH
58.97-
412PhosphorylationQPLGPPATPPGSPPC
CCCCCCCCCCCCCCC
35.4726074081
416PhosphorylationPPATPPGSPPCSLLL
CCCCCCCCCCCCEEE
31.2926074081
420PhosphorylationPPGSPPCSLLLDSSL
CCCCCCCCEEECCCC
28.0326074081
426PhosphorylationCSLLLDSSLSSNWDD
CCEEECCCCCCCCCC
31.7522817900
441PhosphorylationDSLGPSLSPEAVLAR
CCCCCCCCHHHHHHH
25.6522817900
449PhosphorylationPEAVLARTVGSTSTP
HHHHHHHHCCCCCCC
24.5028102081
452PhosphorylationVLARTVGSTSTPRSR
HHHHHCCCCCCCCCC
18.1729396449
453PhosphorylationLARTVGSTSTPRSRC
HHHHCCCCCCCCCCC
30.5928985074
454PhosphorylationARTVGSTSTPRSRCT
HHHCCCCCCCCCCCC
37.8028176443
455PhosphorylationRTVGSTSTPRSRCTP
HHCCCCCCCCCCCCC
23.8625849741
458PhosphorylationGSTSTPRSRCTPRDA
CCCCCCCCCCCCCHH
32.6723312004
461PhosphorylationSTPRSRCTPRDALDL
CCCCCCCCCCHHCCH
21.9022817900
469PhosphorylationPRDALDLSDINSEPP
CCHHCCHHHCCCCCC
35.7930266825
473PhosphorylationLDLSDINSEPPRGSF
CCHHHCCCCCCCCCC
52.3823927012
479PhosphorylationNSEPPRGSFPSFEPR
CCCCCCCCCCCCCCH
34.9523401153
482PhosphorylationPPRGSFPSFEPRNLL
CCCCCCCCCCCHHHH
39.9930266825
490PhosphorylationFEPRNLLSLFEDTLD
CCCHHHHHHHHHCCC
33.8929485707
495PhosphorylationLLSLFEDTLDPT---
HHHHHHHCCCCC---
26.3412738781
499PhosphorylationFEDTLDPT-------
HHHCCCCC-------
51.4120873877

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
426SPhosphorylationKinasePLK1P53350
Uniprot
495TPhosphorylationKinasePLK1P53350
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PMYT1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PMYT1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PIN1_HUMANPIN1physical
9499405
MK08_HUMANMAPK8physical
19204086
MK10_HUMANMAPK10physical
19204086

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PMYT1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40; SER-50; SER-120;SER-469 AND SER-473, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-17; SER-94; SER-120;SER-143; SER-160; SER-469 AND THR-495, AND MASS SPECTROMETRY.
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry.";
Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.;
Mol. Cell. Proteomics 6:537-547(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94, AND MASSSPECTROMETRY.
"Identification of a consensus motif for Plk (Polo-like kinase)phosphorylation reveals Myt1 as a Plk1 substrate.";
Nakajima H., Toyoshima-Morimoto F., Taniguchi E., Nishida E.;
J. Biol. Chem. 278:25277-25280(2003).
Cited for: PHOSPHORYLATION AT SER-426 AND THR-495.

TOP